OPKO Health (OPK) Earnings Analysis

OPKO Health (OPK) next reports earnings on 2026-07-30, consensus EPS -0.08 USD. Last quarter (2026-02-26) it beat with EPS -0.04 USD vs -0.07 USD est (+42.9%). It has beaten estimates in 3/5 recent quarters (60%). Trailing P/E -4.29.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does OPK next report earnings?

Next earnings date2026-07-30
Consensus EPS estimate-0.08 USD
Revenue estimate0.13B

OPK earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-02-26-0.04 USD-0.07 USD+42.9%Beat
2025-10-290.03 USD-0.02 USD+250%Beat
2025-07-31-0.19 USD-0.12 USD-58.3%Miss
2025-04-30-0.1 USD-0.06 USD-66.7%Miss
2025-02-270.01 USD-0.08 USD+112.5%Beat

Beat rate: 3/5 (60%) over reported quarters with consensus data.

OPK valuation and analyst view

Trailing P/E-4.29
Trailing EPS-0.28057 USD
Price / book0.74
Dividend yield0.00%
Market cap0.90B
Analyst consensusBuy (8 buy / 4 hold / 1 sell)
Avg price target1.6 USD

Related research pages

Frequently asked questions

When is OPKO Health (OPK)'s next earnings date?

OPKO Health is next scheduled to report on 2026-07-30, with a consensus EPS estimate of -0.08 USD and revenue estimate of 0.13B.

Did OPK beat earnings last quarter?

In its 2026-02-26 report, OPK posted EPS of -0.04 USD versus a -0.07 USD estimate — a beat of 42.9%.

What is OPK's earnings track record?

Over the last 5 reported quarters with consensus data, OPK beat estimates 3 times (60%).

What is OPK's current P/E ratio and EPS?

OPK trades at a trailing P/E of -4.29 on trailing EPS of -0.2805661050884023 USD.

What do analysts rate OPK?

Analyst consensus is "Buy" across 13 ratings (0 strong buy, 8 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 1.6 USD.